NCOA3 and prostate carcinoma: Another report have shown that SRC-3, in contrast to SRC-2, stimulates proliferation of androgen-dependent and androgen-independent prostate cancer cell and tumour growth [61], indicating a different role of SRC-2 in these types of cancer.